AI正在推动医学领域的革命性突破。Eli Lilly研发的三重激动剂retatrutide能有效溶解脂肪,解决肥胖及其下游后果问题。肥胖自工业革命以来已成为现代文明的严重挑战,如今正被攻克。新型药物使黑色素瘤、胰腺癌等曾无法治疗的癌症变得可治疗,同时GLP-1激动剂还具有抗炎等益处。我们正进入Demis Hassabis所说的“科学黄金时代”,见证科学潜力全面展现。
We are witnessing a revolution in medicine driven by AI. Dreams are turning into reality right before our eyes.
Obesity is becoming a problem of the past. Eli Lilly's triple agonist, retatrutide, melts fat away, and with it the many downstream consequences of obesity. Since the Industrial Revolution, obesity has grown into one of the most serious problems of modern civilization - and now it is being solved. Literally.
Cancers that were once untreatable are becoming treatable thanks to new medicines: melanoma, pancreatic cancer, and many more. And that's before mentioning the other benefits of GLP-1 agonists, such as their anti-inflammatory effects.
We are entering what Demis Hassabis calls the "golden age of science." Anyone willing to open their eyes can see it. Science is unfolding in all its potential right in front of us.